Found 544 hits.
| 194 | Hiraoka, K., Tashiro, M., Grobosch, T., Maurer, M. Oda, K., Toyohara, J., Ishii, K., Ishiwata, K., and Yanai, K.+: Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine. Expert Opin. Drug. Saf. 2014: 14; 1-8. IF: 2.91 |
| 33. | Schoepke, N., Doumoulakis, G., and Maurer, M.+: Diagnosis of urticaria. In: Godse, K., editor: Urticaria. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd., 2016 |
bc.33
| 87 | Magerl, M., Pisarevskaja, D., Scheufele, R., Zuberbier, T., and Maurer, M.+: Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: A prospective trial. Allergy 2010: 65; 78-83. IF: 6.29 |
| 364 | Kulthanan, K., Chularojanamontri, L., Rujitharanawong, C., Weerasubpong, P., Maurer, M.+*, and Weller, K.*: Angioedema quality of life questionnaire (AE-QoL) – interpretability and sensitivity to change. Health. Qual. Life Outcomes 2019: 17; 160. IF: 2.34 |
o.364
| 129. | Maurer, M., Metz, M., Brehler, R., Hillen, U., Jakob, T., Mahler, V., Pföhler, C., Staubach, P., Treudler, R., Wedi, B., and Magerl, M.: Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence. J. Allergy Clin. Immunol. 2018: 141; 638-649. IF: 14.11 |
r.129
| 359 | Bygum, A.+, Caballero, T., Grumach, A. S., Longhurst, H. J., Bouillet, L., Aberer, W., Zanichelli, A., Botha, J., Andresen, I., Maurer, M. for the IOS study group: Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the icatibant outcome survey. Clin. Transl. Allergy 2019: 9; 37. IF: 5.13 |
o.359
| 158. | Maurer, M.+, Eyerich, K., Eyerich, S., Ferrer, M., Gutermuth, J., Hartmann, K., Jakob, T., Kapp, A., Kolkhir, P., Larenas-Linnemann, D., Park, H.-S., Pejler, G., Sanchez-Borges, M., Schäkel, K., Simon, D., Simon, H.-U., Weller, K., Zuberbier, T., and Metz, M.: Urticaria: Collegium Internationale Allergologicum (CIA) update 2020. Int. Arch. Allergy Immunol. 2020: 181; 321-333. IF: 2.75 |
r.158
| 381. | Dortas, S. D. Jr.+, Oliveira Rodrigues Valle, S., Weller, K., Maurer, M., and Lupi, O.: Validity, reliability and interpretability of the Brazilian UCT. Allergy Asthma Proc. 2020: 41; e61-e66. IF: 2.59 |
o.381
| 106 | Brzoza, Z.+, Badura-Brzoza, K., Młynek, A., Magerl, M., Baiardini, I., Canonica, G. W., Weller, K., Kocatürk, E., Kalogeromitros, D., Zalewska-Janowska, A., Zuberbier, T., and Maurer, M.: Adaptation and initial results of the polish version of the GA²LEN chronic urticaria quality of life questionnaire (CU-Q2oL). J. Dermatol. Sci. 2011: 62; 36-41. IF: 3.71 |
| 109 | Eller, K., Wolf, D., Huber, J. M., Metz, M., Mayer, G., McKenzie A. N. J., Maurer, M. Rosenkranz, A. R.+, and Wolf, A. M.: IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune-suppression. J. Immunol. 2011: 186; 83-91. IF: 5.78 |